Wall Street Zen cut shares of indie Semiconductor (NASDAQ:INDI – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. A number of other equities research analysts also recently commented on INDI. UBS Group lifted their price target on shares of indie Semiconductor from $4.50 to $5.00 […]

Wall Street Zen lowered shares of PubMatic (NASDAQ:PUBM – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. A number of other analysts have also recently weighed in on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of PubMatic in a research report […]

Wall Street Zen cut shares of Neurogene (NASDAQ:NGNE – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday morning. Several other research firms have also issued reports on NGNE. HC Wainwright lifted their price target on shares of Neurogene from $65.00 to $70.00 and gave […]

Wall Street Zen lowered shares of Expedia Group (NASDAQ:EXPE – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Saturday. A number of other equities research analysts have also recently issued reports on EXPE. Deutsche Bank Aktiengesellschaft boosted their price objective on Expedia Group from $185.00 […]

Wall Street Zen lowered shares of Mastercraft Boat (NASDAQ:MCFT – Free Report) from a strong-buy rating to a buy rating in a report published on Saturday. A number of other brokerages also recently issued reports on MCFT. Zacks Research downgraded shares of Mastercraft Boat from a “strong-buy” rating to a “hold” rating in a report […]

Wall Street Zen lowered shares of Abivax (NASDAQ:ABVX – Free Report) from a hold rating to a sell rating in a research report released on Saturday. Several other analysts have also commented on the company. Guggenheim raised their target price on Abivax from $101.00 to $150.00 and gave the stock a “buy” rating in a […]

Wall Street Zen lowered shares of Peraso (NASDAQ:PRSO – Free Report) from a hold rating to a sell rating in a research note released on Saturday morning. Several other analysts have also recently commented on PRSO. Benchmark restated a “buy” rating and issued a $3.00 target price on shares of Peraso in a research note […]

Wall Street Zen lowered shares of Contineum Therapeutics (NASDAQ:CTNM – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday morning. Other equities analysts also recently issued research reports about the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Contineum Therapeutics in a […]

Wall Street Zen cut shares of Upexi (NASDAQ:UPXI – Free Report) from a hold rating to a sell rating in a report published on Monday morning. UPXI has been the topic of several other research reports. Weiss Ratings restated a “sell (d+)” rating on shares of Upexi in a research note on Monday, December 1st. […]

Wall Street Zen cut shares of Predictive Oncology (NASDAQ:POAI – Free Report) to a strong sell rating in a research report sent to investors on Saturday morning. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Predictive Oncology in a report on Wednesday, October 8th. One research analyst has rated the stock with […]

Wall Street Zen downgraded shares of Trustmark (NASDAQ:TRMK – Free Report) from a hold rating to a sell rating in a research note released on Saturday. TRMK has been the subject of a number of other research reports. Weiss Ratings reiterated a “buy (b-)” rating on shares of Trustmark in a report on Wednesday, October […]

Wall Street Zen downgraded shares of 4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) from a hold rating to a sell rating in a research note released on Saturday. Other analysts have also recently issued research reports about the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of 4D Molecular Therapeutics in a report […]

Wall Street Zen downgraded shares of IREN (NASDAQ:IREN – Free Report) from a hold rating to a sell rating in a report published on Saturday morning. Several other equities research analysts have also commented on IREN. Roth Capital set a $94.00 price objective on shares of IREN and gave the stock a “buy” rating in […]

Wall Street Zen cut shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) from a hold rating to a sell rating in a research note released on Saturday. A number of other analysts have also issued reports on the company. Zacks Research lowered Apogee Therapeutics from a “strong-buy” rating to a “hold” rating in a research […]

Wall Street Zen downgraded shares of Seneca Foods (NASDAQ:SENEA – Free Report) from a strong-buy rating to a buy rating in a research note published on Saturday. Separately, Weiss Ratings restated a “buy (b-)” rating on shares of Seneca Foods in a research report on Monday, December 1st. One analyst has rated the stock with […]

Wall Street Zen downgraded shares of OPAL Fuels (NASDAQ:OPAL – Free Report) from a hold rating to a sell rating in a research note released on Saturday morning. Several other brokerages also recently commented on OPAL. Zacks Research raised shares of OPAL Fuels from a “strong sell” rating to a “hold” rating in a research […]

Wall Street Zen cut shares of Exelixis (NASDAQ:EXEL – Free Report) from a strong-buy rating to a buy rating in a research report report published on Saturday. EXEL has been the topic of several other reports. Barclays increased their price objective on shares of Exelixis from $40.00 to $41.00 and gave the stock an “equal […]

Wall Street Zen lowered shares of Chagee (NASDAQ:CHA – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday. Other equities analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. began coverage on shares of Chagee in a report on Friday, […]